BioLineRx Ltd. Profit Loss From Continuing Operations Attributable To Ordinary Equity Holders Of Parent Entity
BioLineRx Ltd. (BLRX) reported Profit Loss From Continuing Operations Attributable To Ordinary Equity Holders Of Parent Entity of -$2.03 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity · last filed 2026-03-23
| Period end | Profit Loss From Continuing Operations Attributable To Ordinary Equity Holders Of Parent Entity 12 month |
|---|---|
| 2025-12-31 | -$2.03M 20-F · filed 2026-03-23 |
| 2024-12-31 | -$9.22M 20-F · filed 2026-03-23 |
| 2023-12-31 | -$60.61M 20-F · filed 2026-03-23 |
| 2022-12-31 | -$24.95M 20-F · filed 2025-03-31 |
| 2021-12-31 | -$27.05M 20-F · filed 2024-03-26 |
| 2020-12-31 | -$30.02M 20-F · filed 2023-03-22 |
| 2019-12-31 | -$25.45M 20-F · filed 2022-03-16 |
| 2018-12-31 | -$22.96M 20-F · filed 2021-02-23 |
| 2017-12-31 | -$24.35M 20-F · filed 2020-03-12 |
| 2016-12-31 | -$15.84M 20-F · filed 2019-03-28 |
| 2015-12-31 | -$14.40M 20-F · filed 2018-03-06 |